What does Veracyte, Inc. do?
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis;…
What is Veracyte, Inc.'s P/E and P/B ratio?
Veracyte, Inc. has a P/E ratio of 32.9 and a P/B ratio of 2.67.
What is Veracyte, Inc.'s debt-to-equity ratio?
Veracyte, Inc. has a debt-to-equity ratio of 0.03.
How much does Veracyte, Inc. owe compared with what it owns?
Veracyte, Inc. owes $0.07 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Veracyte, Inc.'s Positivity rank?
Veracyte, Inc. is ranked #3,124 of 6,774 companies globally and #1,236 of 4,000 in United States on PositoAI, with a Positivity Score of 20,846.
Does Veracyte, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Veracyte, Inc..
Where can I read the latest news about Veracyte, Inc.?
Recent headlines about Veracyte, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Veracyte, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Veracyte, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.